The real‐world application of T‐cell receptor constant beta‐1 chain antibody assay in cutaneous T‐cell lymphoma
British Journal of Haematology · 2025
DOI: 10.1111/bjh.20060 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Haematology, 2025. Verfasst von Olivia Pierog und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Johns Hopkins School of Medicine, Baltimore, Maryland, USA. Hauptthemen laut MEDLINE: Lymphoma, T-Cell, Cutaneous, Skin Neoplasms, Receptors, Antigen, T-Cell, alpha-beta. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 15 Literaturangaben. Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
Identifying aberrant T lymphocytes in peripheral blood is essential for diagnosing Sezary syndrome (SS) and is a prognostic indicator in mycosis fungoides (MF). Flow cytometry using a T‐cell receptor constant beta‐1 chain (TRBC1)‐targeting antibody provides a refined approach for detecting T‐cell clonality. We evaluated the performance of the TRBC1 antibody assay (TRBC1‐aa) in 164 patients, compared to standard flow cytometry methods for assessing T‐cell aberrancy, demonstrating 92.3% sensitivity and 83.5% specificity. TRBC1‐aa accurately excluded clonality in 100% of benign inflammatory dermatoses and improved the detection of residual blood involvement earlier than standard flow cytometry in 66.7% of SS and 25.0% of advanced‐stage MF patients on systemic therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.
- Department of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland, USA.
- Department of Pathology, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.
- Division of Haematological Malignancies and Bone Marrow Transplantation, Department of Oncology, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.
ORCID-Profile: Olivia Pierog, Sima Rozati
Förderung
- NCI NIH HHS
Zitieren
APA
Pierog, O., Craig, T., Jennings, J., Borowitz, M. J., Munjal, A., Owusu-Agyei, M., Weiner, D., Peske, J. D., Paul, S., & Rozati, S. (2025). The real‐world application of T‐cell receptor constant beta‐1 chain antibody assay in cutaneous T‐cell lymphoma. British Journal of Haematology. https://doi.org/10.1111/bjh.20060
Vancouver
Pierog O, Craig T, Jennings J, Borowitz MJ, Munjal A, Owusu-Agyei M, et al. The real‐world application of T‐cell receptor constant beta‐1 chain antibody assay in cutaneous T‐cell lymphoma. British Journal of Haematology. 2025. doi:10.1111/bjh.20060
BibTeX
@article{Pierog2025,
author = {Pierog, Olivia and Craig, Taylor and Jennings, Jacky and Borowitz, Michael J and Munjal, Ananya and Owusu-Agyei, Mariah and Weiner, David and Peske, J David and Paul, Suman and Rozati, Sima},
title = {The real‐world application of T‐cell receptor constant beta‐1 chain antibody assay in cutaneous T‐cell lymphoma},
journal = {British Journal of Haematology},
year = {2025},
doi = {10.1111/bjh.20060}
}
EUVIMED